DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE

DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE was reported 313 times

DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADRENAL ANDROGEN EXCESS 5 0.6250
1 VULVAR MELANOSIS 1 0.3333
2 SUBCUTANEOUS FLUID COLLECTION 2 0.2000
3 CHOANAL STENOSIS 4 0.1667
4 OROPHARYNGEAL CANCER RECURRENT 1 0.1667
5 BLOOD HIV RNA BELOW ASSAY LIMIT 2 0.1333
6 CARDIOVASCULAR EXAMINATION ABNORMAL 1 0.1250
7 HEPATITIS B E ANTIBODY POSITIVE 1 0.0455
8 CSF HIV VIRUS IDENTIFIED 1 0.0435
9 LATENT SYPHILIS 1 0.0435
10 AMNIOTIC MEMBRANE GRAFT 1 0.0385
11 PRODUCT DESICCANT ISSUE 1 0.0294
12 PULMONARY HILAR ENLARGEMENT 1 0.0179
13 CSF VIRUS IDENTIFIED 1 0.0143
14 HIV VIRAEMIA 3 0.0143
15 HERPES SIMPLEX MENINGITIS 1 0.0141
16 RENAL SCAN ABNORMAL 1 0.0141
17 ACUTE HAEMORRHAGIC ULCERATIVE COLITIS 1 0.0116
18 VIRAL LOAD ABNORMAL 2 0.0114
19 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 1 0.0090
20 INTERSTITIAL LUNG ABNORMALITY 1 0.0088
21 TRACHEAL INJURY 1 0.0068
22 BUTTOCK INJURY 2 0.0066
23 PROSTATIC ADENOMA 1 0.0060
24 ALCOHOL USE DISORDER 1 0.0058
25 ACETABULUM FRACTURE 2 0.0053
26 HEPATITIS B CORE ANTIBODY POSITIVE 2 0.0053
27 HEPATITIS A ANTIBODY POSITIVE 1 0.0051
28 VERY LOW DENSITY LIPOPROTEIN INCREASED 1 0.0045
29 HIGH DENSITY LIPOPROTEIN ABNORMAL 1 0.0043
30 HYPERHOMOCYSTEINAEMIA 1 0.0038
31 THORACIC CAVITY DRAINAGE 1 0.0037
32 HEPATITIS C ANTIBODY POSITIVE 1 0.0037
33 HEPATITIS B SURFACE ANTIGEN POSITIVE 1 0.0036
34 ANDROGENETIC ALOPECIA 1 0.0035
35 BLOOD HIV RNA INCREASED 6 0.0033
36 TONGUE EXFOLIATION 1 0.0028
37 BONE DEMINERALISATION 3 0.0028
38 HUMAN PAPILLOMA VIRUS TEST POSITIVE 1 0.0025
39 VIRAL MUTATION IDENTIFIED 9 0.0024
40 VIROLOGIC FAILURE 11 0.0020
41 PRODUCT COATING ISSUE 2 0.0020
42 HYPERLIPASAEMIA 1 0.0019
43 STEATOHEPATITIS 1 0.0019
44 EJACULATION DELAYED 1 0.0018
45 ECZEMA EYELIDS 1 0.0018
46 STRESS AT WORK 2 0.0018
47 ENTERAL NUTRITION 1 0.0017
48 ARTERITIS 1 0.0016
49 BACILLUS INFECTION 1 0.0016
50 GASTRIC ULCER PERFORATION 2 0.0016
51 PATHOGEN RESISTANCE 13 0.0014
52 PELVIC FLUID COLLECTION 1 0.0014
53 JARISCH-HERXHEIMER REACTION 1 0.0014
54 TONGUE PARALYSIS 1 0.0014
55 MYCOBACTERIUM ABSCESSUS INFECTION 1 0.0014
56 CENTRAL OBESITY 1 0.0014
57 PERFORATED ULCER 1 0.0013
58 CRITICAL ILLNESS 1 0.0013
59 GENITAL INFECTION FUNGAL 1 0.0012
60 CEREBRAL VENOUS SINUS THROMBOSIS 1 0.0012
61 AXONAL NEUROPATHY 1 0.0011
62 BLOOD TRIGLYCERIDES ABNORMAL 1 0.0011
63 MACULOPATHY 4 0.0011
64 ABDOMINAL HERNIA 5 0.0011
65 ENDOTRACHEAL INTUBATION 3 0.0011
66 INTRACRANIAL MASS 1 0.0011
67 RED BLOOD CELLS URINE POSITIVE 1 0.0010
68 VIRAL LOAD INCREASED 4 0.0010
69 MUSCLE RUPTURE 4 0.0010
70 BLOOD IRON ABNORMAL 1 0.0010
71 GENOTYPE DRUG RESISTANCE TEST POSITIVE 1 0.0010
72 IMPULSE-CONTROL DISORDER 2 0.0010
73 POLYCYTHAEMIA 2 0.0010
74 CD4 LYMPHOCYTES DECREASED 2 0.0009
75 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 1 0.0009
76 VANISHING BILE DUCT SYNDROME 1 0.0009
77 ESSENTIAL TREMOR 1 0.0009
78 MYOCARDIAL INJURY 1 0.0009
79 POLYDACTYLY 1 0.0009
80 RENAL TUBULAR INJURY 1 0.0008
81 ENCEPHALITIS VIRAL 1 0.0008
82 RETINAL DEGENERATION 1 0.0008
83 ACQUIRED GENE MUTATION 1 0.0008
84 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
85 PRODUCT SIZE ISSUE 4 0.0007
86 BODY MASS INDEX INCREASED 1 0.0007
87 SKIN DEPIGMENTATION 1 0.0007
88 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
89 INTENSIVE CARE 1 0.0007
90 AGE-RELATED MACULAR DEGENERATION 1 0.0007
91 HEPATIC CYTOLYSIS 8 0.0006
92 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
93 GLIOBLASTOMA 1 0.0006
94 DEPRESSION SUICIDAL 2 0.0006
95 THYROIDECTOMY 1 0.0006
96 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
97 OESOPHAGEAL SPASM 1 0.0005
98 DYSENTERY 1 0.0005
99 OSTEOPOROTIC FRACTURE 1 0.0005
100 PSYCHIATRIC DECOMPENSATION 1 0.0005
101 HYPOGEUSIA 1 0.0005
102 LIVE BIRTH 4 0.0005
103 SPUTUM INCREASED 1 0.0005
104 LICHEN PLANUS 1 0.0004
105 POISONING DELIBERATE 4 0.0004
106 PROTEIN URINE PRESENT 2 0.0004
107 GASTROINTESTINAL TUBE INSERTION 1 0.0004
108 PSYCHOMOTOR SKILLS IMPAIRED 1 0.0004
109 SHOCK HAEMORRHAGIC 3 0.0004
110 PSYCHOMOTOR RETARDATION 1 0.0004
111 JOINT LOCK 1 0.0004
112 NEGATIVE THOUGHTS 1 0.0003
113 CRANIOCEREBRAL INJURY 1 0.0003
114 SCOLIOSIS 2 0.0003
115 BRAIN FOG 5 0.0003
116 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
117 HEPATIC NEOPLASM 1 0.0003
118 BREAST ENLARGEMENT 1 0.0003
119 SUSPECTED COVID-19 1 0.0003
120 SKIN INJURY 1 0.0003
121 SKIN MASS 2 0.0003
122 ANXIETY DISORDER 1 0.0003
123 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
124 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
125 HEPATIC FIBROSIS 1 0.0003
126 DEPRESSIVE SYMPTOM 1 0.0003
127 PSYCHIATRIC SYMPTOM 2 0.0003
128 ANHEDONIA 7 0.0003
129 TENDON PAIN 2 0.0003
130 ORAL HERPES 5 0.0003
131 HYPERPHAGIA 1 0.0003
132 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
133 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
134 AORTIC VALVE INCOMPETENCE 1 0.0002
135 HEPATIC PAIN 1 0.0002
136 PRODUCT DISPENSING ISSUE 1 0.0002
137 ERECTILE DYSFUNCTION 6 0.0002
138 TEARFULNESS 1 0.0002
139 BRAIN NEOPLASM MALIGNANT 1 0.0002
140 LOSS OF LIBIDO 2 0.0002
141 PAPILLOEDEMA 1 0.0002
142 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
143 RENAL FUNCTION TEST ABNORMAL 1 0.0002
144 PERSONALITY CHANGE 2 0.0002
145 PREGNANCY WITH IMPLANT CONTRACEPTIVE 1 0.0002
146 HORMONE LEVEL ABNORMAL 1 0.0002
147 INABILITY TO AFFORD MEDICATION 2 0.0002
148 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
149 PNEUMONIA ASPIRATION 5 0.0002
150 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
151 DYSLIPIDAEMIA 1 0.0002
152 DRUG RESISTANCE 5 0.0002
153 PRODUCT USE COMPLAINT 3 0.0002
154 PRODUCT RESIDUE PRESENT 1 0.0002
155 GINGIVITIS 1 0.0002
156 CHOKING SENSATION 1 0.0002
157 ACUTE PULMONARY OEDEMA 1 0.0002
158 SHOCK 4 0.0002
159 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
160 HYPERTRIGLYCERIDAEMIA 1 0.0002
161 URINE ODOUR ABNORMAL 1 0.0002
162 DECREASED INTEREST 1 0.0002
163 POLYNEUROPATHY 2 0.0002
164 HEPATITIS B 1 0.0002
165 BONE DENSITY DECREASED 5 0.0002
166 POISONING 2 0.0002
167 DERMATITIS ALLERGIC 2 0.0002
168 PRODUCT PREPARATION ISSUE 1 0.0002
169 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
170 PRODUCT LABEL ISSUE 1 0.0001
171 OSTEOPOROSIS 6 0.0001
172 ABNORMAL DREAMS 4 0.0001
173 HYPERTRANSAMINASAEMIA 1 0.0001
174 EATING DISORDER 3 0.0001
175 UTERINE LEIOMYOMA 1 0.0001
176 PANCREATITIS ACUTE 3 0.0001
177 ECONOMIC PROBLEM 2 0.0001
178 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
179 PROCEDURAL COMPLICATION 1 0.0001
180 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
181 TREATMENT NONCOMPLIANCE 7 0.0001
182 RENAL CYST 1 0.0001
183 SECOND PRIMARY MALIGNANCY 1 0.0001
184 SKIN PLAQUE 1 0.0001
185 FACIAL PARALYSIS 1 0.0001
186 SCAR 2 0.0001
187 NEUROTOXICITY 2 0.0001
188 BRAIN NEOPLASM 1 0.0001
189 RHINORRHOEA 7 0.0001
190 AGRANULOCYTOSIS 2 0.0001
191 FLANK PAIN 1 0.0001
192 HEPATIC CIRRHOSIS 2 0.0001
193 AFFECT LABILITY 1 0.0001
194 VITAMIN D DEFICIENCY 1 0.0001
195 HEPATOMEGALY 1 0.0001
196 UPPER LIMB FRACTURE 2 0.0001
197 PRODUCT PHYSICAL ISSUE 2 0.0001
198 HELICOBACTER INFECTION 1 0.0001
199 RIB FRACTURE 2 0.0001
200 SKELETAL INJURY 1 0.0001
201 TOOTH LOSS 2 0.0001
202 VENTRICULAR EXTRASYSTOLES 1 0.0001
203 UNINTENDED PREGNANCY 1 0.0001
204 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
205 DYSPHAGIA 9 0.0001
206 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
207 LIVER FUNCTION TEST INCREASED 2 0.0001
208 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
209 NERVE INJURY 1 0.0001
210 HEPATOTOXICITY 2 0.0001
211 NEPHROLITHIASIS 4 0.0001
212 NEOPLASM 1 0.0001
213 GASTRIC HAEMORRHAGE 1 0.0001
214 CAESAREAN SECTION 1 0.0001
215 HYPERLIPIDAEMIA 1 0.0001
216 HEPATITIS C 1 0.0001
217 EMOTIONAL DISTRESS 10 0.0001
218 NOCTURIA 1 0.0001
219 NEURALGIA 2 0.0001
220 WEIGHT INCREASED 18 0.0001
221 CHRONIC KIDNEY DISEASE 6 0.0001
222 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
223 HEPATITIS 2 0.0001
224 MALIGNANT MELANOMA 1 0.0001
225 PRODUCT TASTE ABNORMAL 1 0.0001
226 IMPAIRED GASTRIC EMPTYING 1 0.0001
227 NO ADVERSE EVENT 13 0.0001
228 CARPAL TUNNEL SYNDROME 1 0.0001
229 BLINDNESS UNILATERAL 1 0.0001
230 LIVER FUNCTION TEST ABNORMAL 2 0.0001
231 APATHY 1 0.0001
232 ACUTE MYOCARDIAL INFARCTION 2 0.0001
233 PSYCHOTIC DISORDER 2 0.0001
234 BONE LOSS 1 0.0001
235 ACNE 5 0.0001
236 OSTEOPENIA 1 0.0001
237 OROPHARYNGEAL PAIN 6 0.0001
238 ANKLE FRACTURE 1 0.0001
239 EXPOSURE DURING PREGNANCY 4 0.0001
240 DRUG-INDUCED LIVER INJURY 2 0.0001
241 ULCER 1 0.0001
242 OBESITY 1 0.0001
243 NIGHT SWEATS 2 0.0001
244 MUSCLE TIGHTNESS 1 0.0001
245 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
246 LEUKOPENIA 3 0.0001
247 RENAL IMPAIRMENT 5 0.0001
248 CANDIDA INFECTION 1 0.0001
249 ANGER 2 0.0001
250 NEUTROPENIA 8 0.0001
251 CIRCULATORY COLLAPSE 1 0.0001
252 PARANOIA 1 0.0001
253 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
254 CEREBRAL HAEMORRHAGE 2 0.0001
255 END STAGE RENAL DISEASE 1 0.0001
256 HEPATIC STEATOSIS 1 0.0001
257 PANCYTOPENIA 3 0.0001
258 BACTERIAL INFECTION 1 0.0001
259 FRACTURE 1 0.0001
260 DEPRESSION 12 0.0001
261 SLEEP APNOEA SYNDROME 1 0.0001
262 CHOLESTASIS 1 0.0001
263 CHOKING 1 0.0001
264 ABORTION SPONTANEOUS 2 0.0000
265 CYTOKINE RELEASE SYNDROME 1 0.0000
266 ANXIETY 14 0.0000
267 POLLAKIURIA 2 0.0000
268 OSTEOARTHRITIS 2 0.0000
269 MYALGIA 8 0.0000
270 AMNESIA 3 0.0000
271 MENTAL DISORDER 2 0.0000
272 BLOOD CREATININE INCREASED 3 0.0000
273 PRODUCT DISPENSING ERROR 1 0.0000
274 PRODUCT PRESCRIBING ISSUE 1 0.0000
275 ADVERSE DRUG REACTION 4 0.0000
276 CHROMATURIA 1 0.0000
277 SUICIDAL IDEATION 4 0.0000
278 CHEST PAIN 8 0.0000
279 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
280 PALPITATIONS 5 0.0000
281 OCULAR HYPERAEMIA 2 0.0000
282 PRODUCTIVE COUGH 2 0.0000
283 DRUG INTOLERANCE 4 0.0000
284 PRESYNCOPE 1 0.0000
285 PRODUCT DOSE OMISSION ISSUE 12 0.0000
286 AGEUSIA 1 0.0000
287 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
288 PRODUCT COMPLAINT 1 0.0000
289 HYPERHIDROSIS 5 0.0000
290 PANCREATITIS 2 0.0000
291 DEPRESSED MOOD 2 0.0000
292 BRADYCARDIA 2 0.0000
293 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
294 DISTURBANCE IN ATTENTION 2 0.0000
295 WEIGHT DECREASED 10 0.0000
296 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
297 ANGINA PECTORIS 1 0.0000
298 HYPERSOMNIA 1 0.0000
299 INSOMNIA 9 0.0000
300 RENAL INJURY 1 0.0000
301 IRRITABILITY 2 0.0000
302 HEPATIC FAILURE 1 0.0000
303 SUICIDE ATTEMPT 2 0.0000
304 ADVERSE EVENT 3 0.0000
305 GYNAECOMASTIA 1 0.0000
306 LIMB DISCOMFORT 1 0.0000
307 NERVOUS SYSTEM DISORDER 1 0.0000
308 HYPOTHYROIDISM 1 0.0000
309 LOSS OF CONSCIOUSNESS 4 0.0000
310 LACTIC ACIDOSIS 1 0.0000
311 OSTEONECROSIS 1 0.0000
312 BACK PAIN 7 0.0000
313 EXPIRED PRODUCT ADMINISTERED 1 0.0000
314 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
315 NIGHTMARE 1 0.0000
316 COUGH 8 0.0000
317 SLEEP DISORDER 2 0.0000
318 MOBILITY DECREASED 2 0.0000
319 PAIN 17 0.0000
320 PANIC ATTACK 1 0.0000
321 THROMBOCYTOPENIA 3 0.0000
322 HEPATIC FUNCTION ABNORMAL 1 0.0000
323 PRODUCT USE ISSUE 5 0.0000
324 DYSARTHRIA 1 0.0000
325 HALLUCINATION 2 0.0000
326 INTESTINAL OBSTRUCTION 1 0.0000
327 COLITIS 1 0.0000
328 ARTHRITIS 2 0.0000
329 NAUSEA 20 0.0000
330 DRUG INTERACTION 4 0.0000
331 CARDIAC FAILURE 2 0.0000
332 EXTRA DOSE ADMINISTERED 1 0.0000
333 DRY MOUTH 2 0.0000
334 LUNG NEOPLASM MALIGNANT 1 0.0000
335 TREATMENT FAILURE 2 0.0000
336 RHABDOMYOLYSIS 1 0.0000
337 ROAD TRAFFIC ACCIDENT 1 0.0000
338 DEATH 20 0.0000
339 RENAL FAILURE 3 0.0000
340 GASTROINTESTINAL DISORDER 2 0.0000
341 TINNITUS 1 0.0000
342 RENAL DISORDER 1 0.0000
343 ARRHYTHMIA 1 0.0000
344 DISEASE RECURRENCE 1 0.0000
345 RASH ERYTHEMATOUS 1 0.0000
346 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
347 INFECTION 3 0.0000
348 HEART RATE INCREASED 2 0.0000
349 ACUTE KIDNEY INJURY 3 0.0000
350 CHEST DISCOMFORT 2 0.0000
351 ABDOMINAL DISTENSION 2 0.0000
352 HEADACHE 12 0.0000
353 PARAESTHESIA 3 0.0000
354 RASH PRURITIC 1 0.0000
355 HAEMATOCHEZIA 1 0.0000
356 ANAPHYLACTIC REACTION 1 0.0000
357 SEPSIS 2 0.0000
358 PYREXIA 6 0.0000
359 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
360 BONE PAIN 1 0.0000
361 SURGERY 1 0.0000
362 DIARRHOEA 11 0.0000
363 ARTHRALGIA 7 0.0000
364 FATIGUE 13 0.0000
365 ILL-DEFINED DISORDER 1 0.0000
366 VERTIGO 1 0.0000
367 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
368 PRODUCT DOSE OMISSION 1 0.0000
369 PAIN IN EXTREMITY 4 0.0000
370 DYSGEUSIA 1 0.0000
371 UNEVALUABLE EVENT 1 0.0000
372 DIABETES MELLITUS 1 0.0000
373 HOSPITALISATION 2 0.0000
374 DECREASED APPETITE 3 0.0000
375 THROMBOSIS 1 0.0000
376 CONFUSIONAL STATE 2 0.0000
377 DYSPNOEA 7 0.0000
378 CARDIAC ARREST 1 0.0000
379 COMPLETED SUICIDE 1 0.0000
380 TOXICITY TO VARIOUS AGENTS 2 0.0000
381 INTENTIONAL PRODUCT MISUSE 1 0.0000
382 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
383 MUSCLE SPASMS 2 0.0000
384 NASOPHARYNGITIS 2 0.0000
385 ASTHENIA 4 0.0000
386 BLOOD GLUCOSE INCREASED 2 0.0000
387 MIGRAINE 1 0.0000
388 GAIT DISTURBANCE 2 0.0000
389 CONTUSION 1 0.0000
390 SYNCOPE 1 0.0000
391 HYPOTENSION 2 0.0000
392 SOMNOLENCE 2 0.0000
393 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
394 CONDITION AGGRAVATED 3 0.0000
395 RASH 4 0.0000
396 CONSTIPATION 2 0.0000
397 RHEUMATOID ARTHRITIS 1 0.0000
398 SEIZURE 1 0.0000
399 ABDOMINAL PAIN 2 0.0000
400 FEELING ABNORMAL 2 0.0000
401 OEDEMA PERIPHERAL 1 0.0000
402 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
403 DIZZINESS 4 0.0000
404 OFF LABEL USE 7 0.0000
405 PRODUCT QUALITY ISSUE 1 0.0000
406 DRUG INEFFECTIVE 9 0.0000
407 HYPOAESTHESIA 1 0.0000
408 BLOOD PRESSURE INCREASED 1 0.0000
409 PERIPHERAL SWELLING 1 0.0000
410 PNEUMONIA 2 0.0000
411 TREMOR 1 0.0000
412 FALL 2 0.0000
413 ABDOMINAL DISCOMFORT 1 0.0000
414 MYOCARDIAL INFARCTION 1 0.0000
415 COVID-19 1 0.0000
416 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
417 ANAEMIA 1 0.0000
418 ALOPECIA 1 0.0000
419 ABDOMINAL PAIN UPPER 1 0.0000
420 HYPERTENSION 1 0.0000
421 MALAISE 2 0.0000
422 VOMITING 2 0.0000
423 PRURITUS 1 0.0000